Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene - Wikidata - wikimedia - TriplyDB

Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene

Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene

http://www.wikidata.org/entity/Q35553306

about

Identification of rheumatoid arthritis biomarkers based on single nucleotide polymorphisms and haplotype blocks: A systematic review and meta-analysis Association of MTHFR gene polymorphisms with breast cancer survival.Pharmacogenetics and pharmacogenomics in rheumatology.Developmental pharmacogenetics in pediatric rheumatology: utilizing a new paradigm to effectively treat patients with juvenile idiopathic arthritis with methotrexate.Genetically based resistance to the antiinflammatory effects of methotrexate in the air-pouch model of acute inflammation Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?Role of the MTHFR polymorphisms in cancer risk modification and treatment.The Frequency of A1298C and C677T Polymorphisms of the Methylentetrahydrofolate Gene in Turkish Patients with Rheumatoid Arthritis: Relationship with Methotrexate Toxicity.Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis.Genetic Case-Control Study for Eight Polymorphisms Associated with Rheumatoid Arthritis.Pre-administration of turmeric prevents methotrexate-induced liver toxicity and oxidative stress Associations between C677T and A1298C polymorphisms of MTHFR and susceptibility to rheumatoid arthritis: a systematic review and meta-analysis.Pharmacogenetics of rheumatoid arthritis: Potential targets from susceptibility genes and present therapies.Clinical implications of genetic polymorphisms on stomach cancer drug therapy.Genetics of rheumatoid arthritis - a comprehensive review.Pharmacogenomic assessment of outcomes of pemetrexed-treated patients with adenocarcinoma of the lung.Genetic variants associated with methotrexate efficacy and toxicity in early rheumatoid arthritis: results from the treatment of early aggressive rheumatoid arthritis trial.Psoriasis: advances in pathophysiology and management.Psoriatic arthritis: genetic susceptibility and pharmacogenetics.Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms.Gene polymorphisms and pharmacogenetics in rheumatoid arthritis Pharmacogenetic relevance of MTHFR polymorphisms.Genetic polymorphisms of enzyme proteins and transporters related to methotrexate response and pharmacokinetics in a Japanese population.Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic review and meta-analysis.Pharmacogenetics of psoriasis.Pharmacogenetics: implications for therapy in rheumatic diseases.Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases.Methotrexate pharmacogenetics in rheumatoid arthritis: a status report.Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.Potential food-drug interactions in patients with rheumatoid arthritis.Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort.Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?Role of single nucleotide polymorphisms in pharmacogenomics and their association with human diseases.Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.Are gene polymorphisms related to treatment outcomes of methotrexate in patients with rheumatoid arthritis? A systematic review and meta-analysis.Lack of association between MTHFR A1298C polymorphism and outcome of methotrexate treatment in rheumatoid arthritis patients: evidence from a systematic review and meta-analysis.Understanding Personalized Medicine in Rheumatoid Arthritis: A Clinician's Guide to the Future.Methotrexate-induced pancytopenia: a case series of 46 patients.Associations of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms with genetic susceptibility to rheumatoid arthritis: a meta-analysis.

P2860

Q26769061-411E51BC-21EA-4471-89BF-19EDA6B26154 Q33261851-F564D3CC-4A77-4B0B-903B-2CB6D6C96A0C Q34070615-5144E281-7EC6-4E7F-A297-0A02EE99499F Q34219644-317A8F92-8948-4D3E-B187-8564F86E98C9 Q34293811-5F267AC4-1BA4-46C0-829A-2C86D81EB8AA Q34559803-01966F31-C35B-4970-AFC6-432DC734803B Q34658549-FB80C33F-19BD-4A36-85A7-62DCCD81B819 Q35480214-34CD965F-EA27-4EF2-A124-933D74A6C94C Q35637808-32C47C1E-6DE9-4738-8DB5-FB7EFF32D828 Q35683416-0463E704-B13E-475D-9EE3-449249ECDFB2 Q35704644-C7A88FF4-A568-461C-BB90-017A752E3CC6 Q36273637-D840E3B6-13D9-490D-8780-6FD136D837A4 Q36441438-81DEB5EA-F9FC-40DE-B8B2-8639BA9C0E9F Q36519876-863B8E3A-124A-47C4-B82E-D6AC63F30437 Q36847390-3807D398-CC25-4824-997D-AAFA4359F9A1 Q36872919-625BCAD4-FB8F-4DF7-B9F6-215B84ADDF72 Q36983069-52A21CFF-9933-4F20-820B-728865DFBC60 Q36995858-3555A344-F3C2-4A5D-9545-E64FAFFC6239 Q37120837-5DB617EF-D9DD-4E12-BB70-51E18CD1DA88 Q37187337-19A2924C-9336-4D43-8E2C-B46B50DF1D97 Q37214931-9D0E3E71-B14B-48DF-AF2C-83B37E26ED1A Q37264528-855659AE-56CA-4266-AE2C-2A6A5AB6BEF2 Q37491021-BC321017-AAEB-4CFE-9CF3-33C84119C429 Q37725354-531C6109-DEFB-491B-8B18-AEE7B9D71CE2 Q37822759-E2CE5A66-BDE7-41D6-A359-D816CF0458D9 Q37913989-2370B9C0-ABD4-4AF4-BBC8-EC29A7B47AA0 Q37946958-F4A617AE-8199-441D-88A1-4B588956F9F3 Q38080147-D18558F8-194B-495F-9868-DF309F580522 Q38084444-F19E53E5-24B3-40EE-A7ED-8F545E3687FE Q38115004-BB42435E-A313-4E5E-AFA2-60862DE112C5 Q38194466-5C8E86D1-3AA8-485D-A7F1-68CCA6884F6A Q38238947-03CE3904-D9CE-4849-9CA8-73692F007679 Q38495339-2B4F171B-E7F1-4411-B3A1-DCEA882FCFBA Q38501680-BDF20563-18C1-4DE8-A7CF-8FB39B8B3285 Q38936379-B8EF8884-A0F3-4AF5-A35F-CFFE60C04D48 Q39043220-BC841A1B-2E6F-4EB0-9161-FEF79AE35C26 Q39330126-BBCAD886-950A-47BA-8373-6DAC140EF659 Q39991278-1C636C0D-DF1D-410F-B4EC-56557A143444 Q40066665-40568312-1FE3-487D-9BDC-86ACA8F24329 Q40648465-56758E16-5CF8-410B-98E2-68A69CF390B6

P2860

Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene

http://www.wikidata.org/entity/Q35553306

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Methotrexate related adverse e ...... polymorphism of the MTHFR gene

@ast

Methotrexate related adverse e ...... polymorphism of the MTHFR gene

@en

type

label

Methotrexate related adverse e ...... polymorphism of the MTHFR gene

@ast

Methotrexate related adverse e ...... polymorphism of the MTHFR gene

@en

prefLabel

Methotrexate related adverse e ...... polymorphism of the MTHFR gene

@ast

Methotrexate related adverse e ...... polymorphism of the MTHFR gene

@en

P1433

Q35553306-70E158FB-D9A4-4A1C-884E-C60A0EF578D5

P1476

Q35553306-3AC097D6-3B63-460A-91C2-E164F7B7AA09

P2093

Q35553306-0B2A92F0-156A-40FB-80B5-8CEA9015F7D3

Q35553306-2233D607-F43B-442E-A46A-F99DD12E70C2

Q35553306-3D4785D1-2208-4C6A-B843-1EE60859503D

Q35553306-5691B6E3-1A23-4622-8128-207A767AE606

Q35553306-99E2D256-B725-4482-9E21-B10D3264EB90

Q35553306-BA77F172-6CA2-4E27-8C94-3D7734B7223A

Q35553306-C5CCC981-3DC1-4F4A-BD08-885B977AECB7

Q35553306-D9563A0A-B726-4342-B091-9E3EEF909989

Q35553306-DCB43673-3D34-45C6-B77E-239FE0180C50

Q35553306-FF30BCA5-84BF-4EA0-90E9-3600931088EC

P2860

Q35553306-021D3F9B-0B26-43FA-AEF9-574E5D3E37B2

Q35553306-0296D00A-85F0-4013-BD07-A2E461419623

Q35553306-089AB963-8645-4539-B8A1-535E17E4CFCB

Q35553306-2C93E153-16AF-44B6-8608-E54493718794

Q35553306-3C902F10-5F1A-48E3-AACA-E223B1877BD7

Q35553306-42012201-6D08-4774-AB89-124FD7EB75CC

Q35553306-5D2C48F6-E800-4D61-8522-DFE7C5AA054A

Q35553306-6EACAEFF-2558-4DDF-9FFC-82F755E65088

Q35553306-6F96D72F-4A15-45EC-94D0-2A36CA3D0259

Q35553306-8176CB65-66FD-417B-A162-F332A9A050ED

P304

Q35553306-621F5A3A-DF24-4C5E-AA7E-8F4F9646AB91

P31

Q35553306-A98C13E2-1943-4D20-9EC7-5A31EF2C8701

P356

Q35553306-6371D8D2-2A82-47A0-A599-E4271B81F1FE

P407

Q35553306-53E6F4A2-2A8C-4F9C-BB6A-FE5DB390A03D

P433

Q35553306-C3AF9C61-5942-4805-BB19-8BA84274F07E

P478

Q35553306-50093654-1A5E-46EF-A116-BDB05188F509

P577

Q35553306-98157CA6-7FFE-4A7E-A82F-0EAD4D6C97EE

P5875

Q35553306-5C0DC4DF-9C14-4461-8BEA-4E923164B81C

P698

Q35553306-597144D7-54CB-4064-8A10-CD6EC7324DDD

P921

Q35553306-F136DCF7-9E4A-48A2-A5D9-607E1B948FF7

P932

Q35553306-BE3FE08E-6660-493B-8034-18F9F312476F

P356

ARD.2003.016337

P1433

Annals of the Rheumatic Diseases

P1476

Methotrexate related adverse e ...... polymorphism of the MTHFR gene

@en

P2093

Aamar S

http://www.w3.org/2001/XMLSchema#string

Abou Atta I

http://www.w3.org/2001/XMLSchema#string

Ben-Yehuda A

http://www.w3.org/2001/XMLSchema#string

Berkun Y

http://www.w3.org/2001/XMLSchema#string

Friedman G

http://www.w3.org/2001/XMLSchema#string

Grenader T

http://www.w3.org/2001/XMLSchema#string

Levartovsky D

http://www.w3.org/2001/XMLSchema#string

Mevorach D

http://www.w3.org/2001/XMLSchema#string

Orbach H

http://www.w3.org/2001/XMLSchema#string

Rubinow A

http://www.w3.org/2001/XMLSchema#string

P2860

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.

Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis

The cellular pharmacology of methotrexate.

Homocysteine and thrombotic disease.

The mechanism of action of methotrexate.

Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.

A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity.

Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism.

P304

1227-1231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.2003.016337

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8353734

http://www.w3.org/2001/XMLSchema#string

P698

15361376

http://www.w3.org/2001/XMLSchema#string

P921

P932

1754756

http://www.w3.org/2001/XMLSchema#string